| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 25, 2002
Accepted on June 5, 2002
1 Steno Diabetes Center, Niels Steensensvej 6, DK-2820 Gentofte, Denmark (S.G.R., A.E.K., N.B.) Signal Transduction, Novo Nordisk A/S, DK-2880 Bagsværd, Denmark (S.G.R., J.A.H., K.L, N.B.)
* To whom correspondence should be addressed. E-mail: nbil{at}novonordisk.com.
GH (GH) is an important regulator of cell growth and metabolism. In the pancreas, GH stimulates mitogenesis as well as insulin production in ß-cells. The cellular effects of GH are exerted mainly through activation of the JAK-STAT pathway. Recently it has been found that suppressors of cytokine signaling (SOCS) proteins are able to inhibit GH-induced signal transduction. In the present study, the role of SOCS-3 in GH-signaling was investigated in the pancreatic ß-cell lines RIN-5AH and INS-1 by means of inducible expression systems. Via stable transfection of the ß-cell lines with plasmids expressing SOCS-3 under the control of an inducible promoter, a time- and dose-dependent expression of SOCS-3 in the cells was obtained. Electrophoretic mobility shift assay showed that SOCS-3 is able to inhibit GH-induced DNA binding of both STAT3 and STAT5 in RIN-5AH cells. Furthermore, using northern blot analysis it was shown that SOCS-3 can completely inhibit GH-induced insulin production in these cells. Finally, BrdU incorporation followed by FACS-analysis showed that SOCS-3 inhibits GH-induced proliferation of INS-1 cells. These findings support the hypothesis that SOCS-3 is a major regulator of GH signaling in insulin producing cells.
This article has been cited by other articles:
 |
|
 |
|
  G. Kenth, J. A M. Mergelas, and C. G. Goodyer Developmental changes in the human GH receptor and its signal transduction pathways J. Endocrinol., July 1, 2008; 198(1): 71 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen Diabetes and Suppressors of Cytokine Signaling Proteins Diabetes, February 1, 2007; 56(2): 541 - 548. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Frobose, S. Groth Ronn, P. E. Heding, H. Mendoza, P. Cohen, T. Mandrup-Poulsen, and N. Billestrup Suppressor of Cytokine Signaling-3 Inhibits Interleukin-1 Signaling by Targeting the TRAF-6/TAK1 Complex Mol. Endocrinol., July 1, 2006; 20(7): 1587 - 1596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Lindberg, S G Ronn, D Tornehave, H Richter, J A Hansen, J Romer, M Jackerott, and N Billestrup Regulation of pancreatic {beta}-cell mass and proliferation by SOCS-3 J. Mol. Endocrinol., October 1, 2005; 35(2): 231 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Emanuelli, M. Glondu, C. Filloux, P. Peraldi, and E. Van Obberghen The Potential Role of SOCS-3 in the Interleukin-1{beta}-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells Diabetes, December 1, 2004; 53(suppl_3): S97 - S103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Sitko, C. I. Guevara, and N. A. Cacalano Tyrosine-phosphorylated SOCS3 Interacts with the Nck and Crk-L Adapter Proteins and Regulates Nck Activation J. Biol. Chem., September 3, 2004; 279(36): 37662 - 37669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans Endocrinology, September 1, 2004; 145(9): 4162 - 4175. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
